Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
N-Ethylation of substituted ethyl 1H-indole-2-carboxylates with iodoethane and potassium carbonate gave substituted ethyl 1-ethyl-1H-indole-2-carboxylates. The later compounds on treatment with a range of aryl amines with varying structural complexity, gave the desired ethyl 1H-indole-2-carboxamide analogues.J. Heterocyclic Chem., 42, 217 (2005).In the search for new potential and safer antiarrhythmic agents, the present study focuses on the synthesis of selected novel ethyl 1H-indole-2-carboxamide analogues. A variety of antiarrhyhtmic agents (e.g. procainamide, disopyramide, lidocaine, tocainide, and flecanide) [1][2][3][4][5][6][7][8][9][10][11][12][13], containing amide functional groups have shown interesting antiarrhythmic activity [14][15][16][17][18][19][20][21].In view of the wide range of structural diversity of compounds possessing antiarrhythmic activity, efforts to determine a definitive structure have not been too successful. Even some of the more common antiarrhythmic drugs were synthesized for different purposes, when interestingly; upon routine pharmacological screening and clinical trials their antiarrhythmic activity was revealed.The first extensive reviews on the structure activity relationships of antiarrhythmic drugs were by Conn [22]. These investigations indicated that most antiarrhythmic drugs possess a tertiary amine group that appears to be a key component for activity. The aromatic ring system is important and this moiety, is usually connected to the tertiary amine via a hydroxy substituted alkyl chain typically an ester or an amide group, although methoxy groups substituted on the aromatic ring may enhance activity [23][24].Our approach into a new series of some selected analogues is based on the synthesis, chemistry and pharmacological activity of a variety of ethyl 1-ethyl-1H-indole-2-carboxamide analogues. Since the interest in amides have been growing steadily over the years for more targeted biological action [25][26][27][28][29]. This prompted us to design and evaluate a series of novel amides. Scheme 1 illustrates the synthetic approach chosen for the preparation of the amides.The first step involved the reaction of substituted ethyl 1H-indole-2-carboxylates (1a-c, Scheme 1) with iodoethane in the presence of potassium carbonate for the preparation of the desired substituted ethyl 1-ethyl-1H-indole-2-carboxylates (2a-c, Scheme 1). This reaction was exploited following initial experiments to ascertain whether it was necessary to protect the nitrogen atom. It became obvious during these studies in view of the very low yields, that protection of the nitrogen atom in the ring was most probably required to prevent any interaction during the synthesis of the desired amides.Surprisingly, there was no precedence found for this kind of reaction especially with the indole nucleus and the substituents adopted herein. However, the reaction was found to proceed smoothly and afforded the corresponding ethyl 1-ethyl-1H-indole-2-carboxylates (2a-c Scheme 1) albeit in low yields (39% -44%). Att...
N-Ethylation of substituted ethyl 1H-indole-2-carboxylates with iodoethane and potassium carbonate gave substituted ethyl 1-ethyl-1H-indole-2-carboxylates. The later compounds on treatment with a range of aryl amines with varying structural complexity, gave the desired ethyl 1H-indole-2-carboxamide analogues.J. Heterocyclic Chem., 42, 217 (2005).In the search for new potential and safer antiarrhythmic agents, the present study focuses on the synthesis of selected novel ethyl 1H-indole-2-carboxamide analogues. A variety of antiarrhyhtmic agents (e.g. procainamide, disopyramide, lidocaine, tocainide, and flecanide) [1][2][3][4][5][6][7][8][9][10][11][12][13], containing amide functional groups have shown interesting antiarrhythmic activity [14][15][16][17][18][19][20][21].In view of the wide range of structural diversity of compounds possessing antiarrhythmic activity, efforts to determine a definitive structure have not been too successful. Even some of the more common antiarrhythmic drugs were synthesized for different purposes, when interestingly; upon routine pharmacological screening and clinical trials their antiarrhythmic activity was revealed.The first extensive reviews on the structure activity relationships of antiarrhythmic drugs were by Conn [22]. These investigations indicated that most antiarrhythmic drugs possess a tertiary amine group that appears to be a key component for activity. The aromatic ring system is important and this moiety, is usually connected to the tertiary amine via a hydroxy substituted alkyl chain typically an ester or an amide group, although methoxy groups substituted on the aromatic ring may enhance activity [23][24].Our approach into a new series of some selected analogues is based on the synthesis, chemistry and pharmacological activity of a variety of ethyl 1-ethyl-1H-indole-2-carboxamide analogues. Since the interest in amides have been growing steadily over the years for more targeted biological action [25][26][27][28][29]. This prompted us to design and evaluate a series of novel amides. Scheme 1 illustrates the synthetic approach chosen for the preparation of the amides.The first step involved the reaction of substituted ethyl 1H-indole-2-carboxylates (1a-c, Scheme 1) with iodoethane in the presence of potassium carbonate for the preparation of the desired substituted ethyl 1-ethyl-1H-indole-2-carboxylates (2a-c, Scheme 1). This reaction was exploited following initial experiments to ascertain whether it was necessary to protect the nitrogen atom. It became obvious during these studies in view of the very low yields, that protection of the nitrogen atom in the ring was most probably required to prevent any interaction during the synthesis of the desired amides.Surprisingly, there was no precedence found for this kind of reaction especially with the indole nucleus and the substituents adopted herein. However, the reaction was found to proceed smoothly and afforded the corresponding ethyl 1-ethyl-1H-indole-2-carboxylates (2a-c Scheme 1) albeit in low yields (39% -44%). Att...
Abstract-Antiarrhythmic effects of a new antiarrhythmic drug, E-0747, were examined using four canine ventricular arrhythmia models: digitalis-, adrenaline and two-stage coronary ligation-induced arrhythmias and a newly developed locally-induced digitalis arrhythmia. The minimum effective plasma concen tration of E-0747 was determined for the first three arrhythmia models. E-0747 suppressed those arrhythmias, and the minimum effective plasma concentrations for arrhythmias induced by digitalis, adrenaline, 24 hr coronary ligation, and 48 hr coronary ligation were 1.4+0.6, 1.8+0.4, 1.6+0.4 and 2.2±0.2 ,ug/ml, respectively (mean±S.D., n=5-10).The aforementioned minimum effective plasma concen trations of E-0747 for these arrhythmias were almost equal to the reported concen tration in vitro to suppress the Na channels of isolated canine ventricular tissues. The class 1 property of E-0747 was also shown in a newly developed locally induced digitalis arrhythmia. Thus E-0747 suppresses arrhythmia by inhibiting Na channels of cardiac cells and is expected to become a clinically useful anti arrhythmic drug.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.